NL7614389A - Werkwijze ter bereiding van een prostaglandine. - Google Patents

Werkwijze ter bereiding van een prostaglandine.

Info

Publication number
NL7614389A
NL7614389A NL7614389A NL7614389A NL7614389A NL 7614389 A NL7614389 A NL 7614389A NL 7614389 A NL7614389 A NL 7614389A NL 7614389 A NL7614389 A NL 7614389A NL 7614389 A NL7614389 A NL 7614389A
Authority
NL
Netherlands
Prior art keywords
prostaglandin
preparing
Prior art date
Application number
NL7614389A
Other languages
English (en)
Dutch (nl)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NL7614389A publication Critical patent/NL7614389A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02—Magnesium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7614389A 1975-12-29 1976-12-24 Werkwijze ter bereiding van een prostaglandine. NL7614389A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64527675A 1975-12-29 1975-12-29

Publications (1)

Publication Number Publication Date
NL7614389A true NL7614389A (nl) 1977-07-01

Family

ID=24588384

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7614389A NL7614389A (nl) 1975-12-29 1976-12-24 Werkwijze ter bereiding van een prostaglandine.

Country Status (18)

Country Link
US (4) US4081478A (fr)
JP (1) JPS5283351A (fr)
AU (1) AU502349B2 (fr)
BE (1) BE849963A (fr)
CA (1) CA1077473A (fr)
CH (1) CH629747A5 (fr)
DE (1) DE2658207A1 (fr)
ES (1) ES454181A1 (fr)
FR (1) FR2336924A1 (fr)
GB (2) GB1554041A (fr)
HU (1) HU178365B (fr)
IL (1) IL50997A (fr)
MX (1) MX4940E (fr)
NL (1) NL7614389A (fr)
PL (1) PL116421B1 (fr)
SE (1) SE7614584L (fr)
SU (1) SU731895A3 (fr)
ZA (1) ZA767416B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048058A (en) * 1975-08-13 1977-09-13 Standard Oil Company (Indiana) Methods to be used in reforming processes employing multi-metallic catalysts
US4267315A (en) * 1979-05-01 1981-05-12 The Upjohn Company 2-Decarboxy-2-aminomethyl-11a-methano-TXA2 compounds
US4292445A (en) * 1980-04-28 1981-09-29 The Upjohn Company Amide and sulfonamide derivatives of 2-decarboxy-2-aminomethyl-PG-type compounds
CA1241324A (fr) 1984-03-08 1988-08-30 Paul A. Aristoff Derives d'interphenylene carbacycline
US5270049A (en) 1990-11-09 1993-12-14 Allergan, Inc. 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
HU223068B1 (hu) * 1995-12-20 2004-03-01 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás PGE1 prosztanoid előállítására
US7851504B2 (en) * 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
WO2010102078A1 (fr) 2009-03-04 2010-09-10 Allergan, Inc. Solution ophtalmique améliorée à base de bimatoprost
US8476471B2 (en) 2009-07-13 2013-07-02 Irix Pharmaceuticals, Inc. Synthesis of prostanoids
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
HUP1000284A3 (en) * 2010-06-01 2012-08-28 Avidin Kft Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation
KR102311896B1 (ko) 2013-09-30 2021-10-14 패턴 에이피아이 서비시즈 인코포레이티드 복분해를 사용하는 프로스타글란딘 및 프로스타글란딘 중간체의 합성 경로
CN104860860B (zh) * 2015-04-29 2017-09-19 东北制药集团股份有限公司 一种卡前列酯的纯化制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166971A (en) * 1932-09-14 1939-07-25 Ig Farbenindustrie Ag Production of amines
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3647804A (en) * 1970-02-27 1972-03-07 Upjohn Co Cycloalkanecarboxamides
US3852296A (en) * 1971-07-16 1974-12-03 Richardson Merrell Spa Mannich bases of cyclopentanones and cyclopent-2-enones and process of preparing the same
US3987087A (en) * 1971-07-29 1976-10-19 The Upjohn Company Phenyl-substituted prostaglandin-f type analogs
US3954741A (en) * 1972-06-07 1976-05-04 Pfizer Inc. N-substituted prostaglandin carboxamides
US3987085A (en) * 1972-09-15 1976-10-19 The Upjohn Company 8β,11β,12α-PGF2.sub.α compounds

Also Published As

Publication number Publication date
SE7614584L (sv) 1977-06-30
JPS5283351A (en) 1977-07-12
ES454181A1 (es) 1977-12-16
CA1077473A (fr) 1980-05-13
AU2039676A (en) 1978-06-15
US4081478A (en) 1978-03-28
CH629747A5 (de) 1982-05-14
PL116421B1 (en) 1981-06-30
IL50997A (en) 1982-05-31
SU731895A3 (ru) 1980-04-30
US4085139A (en) 1978-04-18
JPS5744666B2 (fr) 1982-09-22
HU178365B (en) 1982-04-28
BE849963A (fr) 1977-06-29
US4073808A (en) 1978-02-14
FR2336924B1 (fr) 1984-08-17
GB1554041A (en) 1979-10-17
MX4940E (es) 1983-01-10
GB1554042A (en) 1979-10-17
DE2658207A1 (de) 1977-07-07
US4122282A (en) 1978-10-24
ZA767416B (en) 1977-11-30
AU502349B2 (en) 1979-07-19
FR2336924A1 (fr) 1977-07-29
IL50997A0 (en) 1977-01-31

Similar Documents

Publication Publication Date Title
NL7701467A (nl) Werkwijze ter bereiding van een prostaglandine.
NL7512897A (nl) Werkwijze ter bereiding van een zetmeel bevattend concentraat.
NL7605663A (nl) Werkwijze ter bereiding van een dimeer.
NL7603368A (nl) Werkwijze ter bereiding van een vertakt polycar- bonaat.
NL179975C (nl) Werkwijze ter bereiding van een geneesmiddel.
NL7706051A (nl) Werkwijze ter bereiding van een farmaceutisch preparaat.
NL7603573A (nl) Werkwijze ter bereiding van een fritcompositie.
NL172237C (nl) Werkwijze ter bereiding van een koolwaterstofhydroperoxyde.
NL7700911A (nl) Werkwijze ter bereiding van een farmaceutisch preparaat.
NL7612570A (nl) Werkwijze ter bereiding van een vast bloed- preparaat.
NL170752C (nl) Werkwijze ter bereiding van een smeervet.
NL7612174A (nl) Werkwijze ter bereiding van een dibenzo(b,d)- pyran.
NL7604848A (nl) Werkwijze ter bereiding van een koper-nikkel- -silica-katalysator samenstelling.
NL183031C (nl) Werkwijze ter bereiding van een 2-(2-chloorsulfinyl-4-oxoazetidine-1-yl)-2-isopropenylazijnzuur derivaat.
NL7604022A (nl) Werkwijze ter bereiding van een chelaat.
NL7613426A (nl) Werkwijze ter bereiding van een geneesmiddel.
NL7505879A (nl) Werkwijze ter bereiding van een nieuwe verbin- ding.
NL7505943A (nl) Werkwijze ter bereiding van een 6-desoxy-5-hy- droxytetracycline.
NL7602642A (nl) Werkwijze ter bereiding van een nieuw antibio- ticum.
NL7603660A (nl) Werkwijze ter bereiding van een kristallijn antibioticum.
NL7511236A (nl) Werkwijze ter bereiding van een katalysator- mengsel.
NL180217C (nl) Werkwijze ter bereiding van een 7beta-amino-7alfa-methoxy-3-cefem-4-carbonzuurester.
NL7709614A (nl) Werkwijze ter bereiding van een vast cefalospo- rinederivaat.
NL7609935A (nl) Werkwijze ter bereiding van een farmaceutisch preparaat.
NL7606431A (nl) Werkwijze ter bereiding van een gemodificeerd polyalkeen-materiaal.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed